Psychemedics (PMD) Declares $0.18 Quarterly Dividend; 5.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Psychemedics (PMD) Reports Q1 EPS of $0.11 on Revenues of $9.8M
April 23, 2019 5:34 PM EDTPsychemedics (NASDAQ: PMD) reported Q1 EPS of $0.11, versus $0.23 reported last year. Revenue for the quarter came in at $9.8 million, versus $10.9 million reported last year.
Raymond C. Kubacki, Chairman and Chief Executive Officer, stated:
"First quarter revenues and earnings were below expectations, and continued to be impacted by negative changes in the Brazilian foreign currency exchange rate.
International revenues showed a decline. While the Driver segment showed some weakness, this was compounded by a decline in the more cyclical Non-Driver business and the negative foreign currency exchange. Our domestic... More
